Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
STD Risk Reduction for Heterosexual Methamphetamine Users
This study is currently recruiting participants.
Study NCT00344214 Information provided by National Institute of Mental Health (NIMH)
First Received: June 23, 2006 Last Updated: March 25, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Substance-Related Disorders
HIV Infections
Sexually Transmitted Diseases
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
Infection
More general conditions related to this trial
Disorders of Environmental Origin
Genital Diseases, Female
Genital Diseases, Male
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Mental Disorders
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
Standard care
Additional drug interventions recognized in this trial
Amphetamine
Methamphetamine
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Uptake Inhibitors
Autonomic Agents
Central Nervous System Agents
Central Nervous System Stimulants
Dopamine Agents
Dopamine Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sympathomimetics
Therapeutic Uses
Sponsors listed in this trial
National Institute of Mental Health (NIMH)
Back to top of Main Content
